Actuate Therapeutics, Inc. (ACTU) Balance Sheet

NASDAQ: ACTUAssets, liabilities, debt and equity over 4 years.

ACTU balance sheet, 2025

December 31, 2025 · U.S. dollars

$14.0M assets = $6.1M liabilities + $7.9M equity

Both columns are drawn to the same scale: what ACTU owns equals what it owes plus shareholders’ equity. Hover a block for its value.

ACTU financial health

Current ratio2.39

Comfortable · current assets cover current liabilities 2.39×

Debt / equity0.05

Low leverage · $0.05 of debt for each $1 of equity

Equity / assets56.5%

Equity-funded · of assets funded by shareholders

Cash / debt3,249.3%

Cash covers debt · cash & short-term investments vs total debt

Goodwill & intangibles0.0%

Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

ACTU balance sheet trends, 2022–2025

Actuate Therapeutics, Inc. balance sheet trends
Metric	Then	Latest	Change
Total assets	$20.5M2022	$14.0M2025	−11.8%/yr
Total liabilities	$5.7M2022	$6.1M2025	+2.6%/yr
Shareholders’ equity	$14.8M2022	$7.9M2025	−18.9%/yr
Cash & short-term investments	$20.4M2022	$13.2M2025	−13.7%/yr
Total debt	$404,9912022	$404,9912025	0.0%/yr
Net cash (debt)	$20.0M2022	$12.8M2025	−$7.3M
Working capital	$16.1M2022	$7.9M2025	−$8.2M
Book value per share	$0.992022	$0.382025	−27.4%/yr
Current ratio	4.712022	2.392025	−2.32
Debt / equity	0.032022	0.052025	+0.02
Shares outstanding	15.0M2022	21.0M2025	+11.8%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

ACTU assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

ACTU liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

ACTU debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

ACTU balance sheet

Actuate Therapeutics, Inc. annual balance sheet
	2025	2024	2023	2022
Assets
Cash & short-term investments	$13.2M	$8.6M	$3.0M	$20.4M
Cash & equivalents	$13.2M	$8.6M	$3.0M	$20.4M
Receivables	$0	$0	$0	$0
Inventory	$0	$0	$0	$0
Other current assets	$483,996	$566,278	$36,907	$33,746
Total current assets	$13.6M	$9.2M	$3.0M	$20.5M
Property, plant & equipment (net)	$0	$0	$0	$0
Goodwill & intangible assets	$0	$0	$0	$0
Long-term investments	$0	$0	$0	$0
Other non-current assets	$392,491	$110,548	$0	$0
Total assets	$14.0M	$9.3M	$3.0M	$20.5M
Liabilities
Accounts payable	$1.5M	$1.9M	$3.4M	$2.1M
Total current liabilities	$5.7M	$8.8M	$6.9M	$4.3M
Long-term debt	$0	$0	$0	$0
Other long-term liabilities	$404,991	$411,759	$95.7M	$1.3M
Total liabilities	$6.1M	$9.2M	$102.6M	$5.7M
Shareholders' equity
Common stock & paid-in capital	$23	$20	$2	$3
Retained earnings (deficit)	−$154.6M	−$132.4M	−$105.1M	−$80.3M
Accumulated other comprehensive income	—	—	$0	—
Total shareholders' equity	$7.9M	$104,186	−$99.6M	$14.8M
Key figures
Total debt	$404,991	$404,991	—	$404,991
Net cash (debt)	$12.8M	$8.2M	—	$20.0M
Working capital	$7.9M	$405,397	−$3.9M	$16.1M
Tangible book value	$7.9M	$104,186	−$99.6M	$14.8M
Book value per share	$0.38	$0.01	−$6.63	$0.99
Shares outstanding	21.0M	19.5M	15.0M	15.0M
Current ratio	2.39	1.05	0.43	4.71
Quick ratio	2.31	0.98	0.43	4.71
Debt / equity	0.05	3.89	—	0.03
Equity / assets	56.5%	1.1%	−3,325.8%	72.4%

Actuate Therapeutics, Inc. quarterly balance sheet
	Jun '26	Mar '26	Dec '25	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24	Dec '23
Assets
Cash & short-term investments	$4.4M	$8.1M	$13.2M	$16.9M	$6.5M	$3.9M	$8.6M	$13.5M	$351,709	$2.1M	$3.0M
Cash & equivalents	$4.4M	$8.1M	$13.2M	$16.9M	$6.5M	$3.9M	$8.6M	$13.5M	$351,709	$2.1M	$3.0M
Receivables	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Other current assets	$322,100	$385,444	$483,996	$519,237	$195,903	$359,159	$566,278	$739,332	$197,978	$119,774	$36,907
Total current assets	$4.7M	$8.5M	$13.6M	$17.4M	$6.7M	$4.2M	$9.2M	$14.3M	$549,687	$2.2M	$3.0M
Property, plant & equipment (net)	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill & intangible assets	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Long-term investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Other non-current assets	$451,398	$391,838	$392,491	$269,933	$280,342	$234,475	$110,548	$0	$1.2M	$510,502	$0
Total assets	$5.2M	$8.9M	$14.0M	$17.7M	$7.0M	$4.5M	$9.3M	$14.3M	$1.7M	$2.7M	$3.0M
Liabilities
Accounts payable	$1.1M	$1.2M	$1.5M	$1.2M	$3.2M	$2.6M	$1.9M	$2.3M	$5.9M	$4.0M	$3.4M
Short-term debt	—	—	—	—	—	—	—	—	$6.9M	$5.0M	—
Total current liabilities	$3.8M	$4.7M	$5.7M	$6.4M	$9.2M	$9.2M	$8.8M	$8.5M	$20.1M	$14.7M	$6.9M
Long-term debt	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Other long-term liabilities	$404,991	$404,990	$404,991	$404,991	$421,884	$416,822	$411,759	$406,683	$95.9M	$95.7M	$95.7M
Total liabilities	$4.2M	$5.1M	$6.1M	$6.8M	$9.6M	$9.6M	$9.2M	$8.9M	$116.0M	$110.5M	$102.6M
Shareholders' equity
Common stock & paid-in capital	$24	$24	$23	$23	$20	$20	$20	$20	$2	$2	$2
Retained earnings (deficit)	−$165.1M	−$160.2M	−$154.6M	−$150.1M	−$144.6M	−$138.7M	−$132.4M	−$125.9M	−$120.0M	−$113.4M	−$105.1M
Accumulated other comprehensive income	—	—	—	$0	$0	—	—	—	—	—	—
Total shareholders' equity	$989,152	$3.8M	$7.9M	$10.9M	−$2.7M	−$5.1M	$104,186	$5.4M	−$114.3M	−$107.8M	−$99.6M
Key figures
Total debt	$404,991	$404,991	$404,991	—	$404,991	—	$404,991	$404,991	$6.9M	$5.0M	—
Net cash (debt)	$4.0M	$7.7M	$12.8M	—	$6.1M	—	$8.2M	$13.1M	−$6.5M	−$2.9M	—
Working capital	$942,745	$3.8M	$7.9M	$11.1M	−$2.5M	−$4.9M	$405,397	$5.8M	−$19.5M	−$12.5M	−$3.9M
Tangible book value	$989,152	$3.8M	$7.9M	$10.9M	−$2.7M	−$5.1M	$104,186	$5.4M	−$114.3M	−$107.8M	−$99.6M
Book value per share	$0.04	$0.16	$0.34	$0.51	−$0.14	−$0.26	$0.01	$0.27	−$5.85	−$6.96	−$6.53
Shares outstanding	23.9M	23.5M	23.2M	21.4M	19.6M	19.5M	19.5M	19.5M	19.5M	15.5M	15.3M
Current ratio	1.25	1.80	2.39	2.74	0.73	0.46	1.05	1.68	0.03	0.15	0.43
Quick ratio	1.16	1.72	2.31	2.66	0.71	0.42	0.98	1.59	0.02	0.14	0.43
Debt / equity	0.41	0.11	0.05	—	—	—	3.89	0.08	—	—	—
Equity / assets	19.0%	42.5%	56.5%	61.7%	−38.1%	−113.5%	1.1%	37.6%	−6,601.3%	−3,993.7%	−3,325.8%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 26, 2026); data from EODHD.

ACTU financial position

At the end of fiscal 2025 (December 31, 2025), Actuate Therapeutics had total assets of $14.0 million (up 50.6% from a year earlier), total liabilities of $6.1 million and shareholders' equity of $7.9 million. It held $13.2 million in cash and short-term investments against $0.4 million of debt, a net cash position of $12.8 million. Its current ratio was 2.39. In the latest quarter (ended June 30, 2026) total assets were $5.2 million and equity $1.0 million.

Related: ACTU income statement, ACTU cash flow statement, ACTU key metrics. See the ACTU stock overview for the latest quote and news.

ACTU balance sheet FAQ

What are Actuate Therapeutics's total assets?

Actuate Therapeutics reported total assets of $14.0 million at the end of fiscal 2025 (December 31, 2025), compared with $9.3 million a year earlier.

How much debt does Actuate Therapeutics have?

Actuate Therapeutics had $0.4 million of total debt at the end of fiscal 2025, including short-term borrowings. Its debt-to-equity ratio was 0.05.

How much cash does Actuate Therapeutics have?

Actuate Therapeutics held $13.2 million in cash and short-term investments at the end of fiscal 2025; with $0.4 million of debt that is net cash of $12.8 million.

What is Actuate Therapeutics's book value?

Actuate Therapeutics's shareholders' equity (book value) was $7.9 million at the end of fiscal 2025, or $0.38 per share.

What is Actuate Therapeutics's current ratio?

Actuate Therapeutics had current assets of $13.6 million and current liabilities of $5.7 million, a current ratio of 2.39 (it can cover its short-term obligations).